Clinical Trial Detail

NCT ID NCT02323607
Title Pacritinib and Chemotherapy in Treating Patients With Acute Myeloid Leukemia and FLT3 Mutations
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Bhavana Bhatnagar
Indications

acute myeloid leukemia

Therapies

Cytarabine + Daunorubicin + Pacritinib

Decitabine + Pacritinib

Age Groups: adult

Additional content available in CKB BOOST